Literature DB >> 7033468

Ultrastructural and chemical studies on wall-deficient forms, spheroplasts and membrane vesicles from Mycobacterium aurum.

N Rastogi, H L David.   

Abstract

Wall-deficient forms of Mycobacterium aurum were prepared by agitating the cells during exponential growth with D-cycloserine, glycine, lysozyme, EDTA and LiCl for approximately the time of three cell divisions (18 h). Wall-deficient forms were then converted to spheroplasts by gentle stirring with lysozyme and EDTA in a Tris/HCl buffer containing sucrose until all the cells appeared spherical by phase contrast microscopy. Subsequent lysis by nucleases followed by osmotic shock produced membrane vesicles. Ultrastructural and chemical properties of the spheroplasts and membrane vesicles are described. The spheroplasts were susceptible to lysis by 0.25% (w/v) sodium dodecyl sulphate and were permeable to certain enzyme substrates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033468     DOI: 10.1099/00221287-124-1-71

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  8 in total

Review 1.  Gene manipulation in mycobacteria.

Authors:  J Konícek; M Konícková-Radochová; M Slosárek
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 2.  Techniques for genetic engineering in mycobacteria. Alternative host strains, DNA-transfer systems and vectors.

Authors:  J Hermans; J A de Bont
Journal:  Antonie Van Leeuwenhoek       Date:  1996-04       Impact factor: 2.271

3.  A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae--a possible vaccine.

Authors:  J Marolia; P Robinson; P R Mahadevan
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Lipoarabinomannan localization and abundance during growth of Mycobacterium smegmatis.

Authors:  Rakesh K Dhiman; Premkumar Dinadayala; Gavin J Ryan; Anne J Lenaerts; Alan R Schenkel; Dean C Crick
Journal:  J Bacteriol       Date:  2011-08-12       Impact factor: 3.490

5.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.

Authors:  N Rastogi; K S Goh; H L David
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

7.  Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?

Authors:  N Rastogi; C Frehel; A Ryter; H Ohayon; M Lesourd; H L David
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

8.  Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids.

Authors:  Marianne S Jurkowitz; Abul K Azad; Paula C Monsma; Tracy L Keiser; Jean Kanyo; TuKiet T Lam; Charles E Bell; Larry S Schlesinger
Journal:  J Biol Chem       Date:  2022-03-18       Impact factor: 5.486

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.